Developments Aerie Pharma upsizes and prices private sale of $275-million of convertible notes Aerie Pharmaceuticals (NASDAQ:AERI) priced $275-million principal amount of 1.5% convertible senior notes due 2024. The offering was increased to $275-million from a previously announced size of $250-million. The notes... September 5, 2019